Welcome to our dedicated page for Varex Imaging news (Ticker: VREX), a resource for investors and traders seeking the latest updates and insights on Varex Imaging stock.
Varex Imaging Corporation (Nasdaq: VREX) is the world’s largest independent supplier of medical X-ray tubes and image processing solutions. With a mission to be the leader in imaging components by delivering high-quality products that enable customer success, Varex Imaging serves a variety of industries, from medical imaging to cargo screening and border security.
Core Business: Varex Imaging operates in two main segments: Medical and Industrial. The Medical segment, the key revenue driver, designs, manufactures, sells, and services a range of X-ray imaging components such as X-ray tubes, digital flat panel image detectors, high voltage connectors, ionization chambers, and buckys. The Industrial segment focuses on components like Linatron X-ray accelerators, digital flat panel detectors, and high voltage connectors. These components are integral to X-ray imaging systems used worldwide for diagnosis, detection, and protection.
Recent Achievements and Projects: Varex Imaging has an extensive catalog of innovative and cost-effective X-ray imaging solutions. The company conducts manufacturing, research, and development operations in the United States, Europe, the Philippines, and China, with sales and service operations globally. Varex's commitment to innovation is evident through its continual development of high-voltage connectors, X-ray collimators, ionization chambers, and mammography paddles, among others.
Financial and Partnerships: Varex Imaging has solidified its position in the market through strategic partnerships and a robust financial outlook. The company's products help their customers become world-class system suppliers by harnessing the power of X-ray energy to pioneer advances in various applications.
Overall, Varex Imaging Corporation stands out as a key player in the imaging components industry, driving advancements that benefit both medical and industrial applications.
Varex Imaging Corporation (Nasdaq: VREX) will announce its unaudited financial results for Q4 and full fiscal year 2021 on November 16, 2021, after market close. Following the earnings release, a conference call will take place at 3:00 PM Mountain Time, which will be available via webcast on their website. Investors can also access the call through specific phone numbers. A replay will be offered until November 30. Varex specializes in X-ray imaging components for medical, industrial, and security applications, supported by over 70 years of innovation.
Varex Imaging Corporation (Nasdaq: VREX) reported strong financial results for the third quarter of fiscal year 2021, with revenues of $211 million, reflecting a 4% sequential increase and a 23% year-over-year rise, propelled by demand in Medical and Industrial segments. The non-GAAP gross margin improved to 36%, while GAAP operating margin reached 12%. The company generated $22 million in cash flow from operations and strengthened its balance sheet by increasing cash equivalents to $128 million. For the fourth quarter, Varex anticipates revenues between $205 million and $225 million and non-GAAP earnings per share of $0.25 to $0.40.
Varex Imaging Corporation (Nasdaq: VREX) will release its unaudited financial results for Q3 FY2021 after market close on August 3, 2021. This will be followed by a conference call at 3:00 PM Mountain Time, which will be accessible via the company's website or through designated phone numbers for U.S. and non-U.S. callers. The call will be archived online, with a replay available from August 3rd to August 17th.
Varex specializes in X-ray imaging components, serving medical, industrial, and security sectors, with a workforce of approximately 2,000 globally.
Varex Imaging Corporation (Nasdaq: VREX) has launched the LUMEN 4336W digital radiography detector, enhancing its product line with features prioritizing durability and convenience. This new detector features a robust design with an IP68 rating, ensuring water resistance for real-world applications. It emphasizes reliability through a simplified internal structure and incorporates wireless charging capabilities. Varex continues to guarantee high image quality, leveraging its expertise in X-ray imaging technology.
Varex Imaging Corporation (Nasdaq: VREX) announced a partial redemption of $30 million from its $300 million 7.875% senior secured notes due 2027, effective July 15, 2021. The redemption price is set at 103% of the principal amount plus accrued interest since April 15, 2021. CFO Sam Maheshwari highlighted that improved financial performance is enabling debt reduction and decreased interest expenses, indicating a positive cash generation trend for the company.
Varex Imaging Corporation (Nasdaq: VREX) is set to present at the Jefferies Virtual Healthcare Conference on June 2, 2021, at 9:30 am ET. The company's CFO, Sam Maheshwari, will discuss Varex’s business and future prospects during the presentation. This event will be available via webcast, with replays accessible for 90 days on the company's website, vareximaging.com. Varex, headquartered in Salt Lake City, Utah, specializes in X-ray imaging components used in medical and industrial applications, boasting over 70 years of innovation.
Varex Imaging Corporation (Nasdaq: VREX) reported strong financial performance for 2QFY21, with revenues of $204 million, a 15% sequential increase, and a 3% year-over-year rise. The company achieved a GAAP gross margin of 32% and a non-GAAP gross margin of 35%. Net earnings were $0.08 per diluted share for GAAP and $0.35 for non-GAAP. Positive drivers included robust global sales of CT tubes and industrial digital detectors. Cash flow from operations reached $13 million, and cash and equivalents stood at $111 million by quarter end.
Varex Imaging Corporation (Nasdaq: VREX) will report its unaudited financial results for Q2 of fiscal year 2021 on May 4, 2021, after market close. A conference call is scheduled for the same day at 3:00 p.m. Mountain Time, accessible through the company's website or via phone. Varex specializes in X-ray imaging components and has over 70 years of innovation, providing solutions for medical, industrial, and security imaging applications. The company employs around 2,000 people globally, reflecting its strong presence in the imaging sector.
Varex Imaging Corporation (Nasdaq: VREX) will present at the Oppenheimer 31st Annual Healthcare Conference on March 17, 2021, at 1:10 pm ET. The company’s CFO, Sam Maheshwari, will discuss Varex’s business and future prospects. The presentation will be webcast and accessible on the company’s website, with replays available for 90 days. Varex specializes in designing and manufacturing X-ray imaging components, playing a crucial role in medical and industrial applications, with over 2,000 employees worldwide.
Varex Imaging Corporation (Nasdaq: VREX) reported its 1QFY21 financial results, showing revenues of $177 million, a 4% increase sequentially from 4QFY20. The company achieved a GAAP gross margin of 32% and a non-GAAP gross margin of 34%, reflecting a 580 basis points improvement due to cost reductions and a favorable product mix. GAAP net earnings were $(0.16) per diluted share, while non-GAAP earnings were $0.08. The outlook for 2QFY21 estimates revenues between $180 million and $200 million and non-GAAP earnings per diluted share between $0.05 and $0.25.
FAQ
What is the current stock price of Varex Imaging (VREX)?
What is the market cap of Varex Imaging (VREX)?
What does Varex Imaging Corporation do?
What are the main segments of Varex Imaging’s business?
Where are Varex Imaging’s operations located?
What products does Varex Imaging manufacture?
What industries use Varex Imaging’s products?
How does Varex Imaging contribute to innovation?
What is the mission of Varex Imaging Corporation?
Which segment is the key revenue driver for Varex Imaging?
Who are the customers of Varex Imaging?
What are some recent achievements of Varex Imaging?
